The immunoglobulin‐like domain of neuregulins potentiates ErbB3/HER3 activation and cellular proliferation
The neuregulins (NRGs) represent a large family of membrane‐anchored growth factors, whose deregulation may contribute to the pathogenesis of several tumors. In fact, targeting of NRG‐activated pathways has demonstrated clinical benefit. To improve the efficacy of anti‐NRG therapies, it is essential...
Main Authors: | Ariana Centa, Ruth Rodríguez‐Barrueco, Juan Carlos Montero, Atanasio Pandiella |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-06-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12310 |
Similar Items
-
On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity
by: Ada Ledonne, et al.
Published: (2019-12-01) -
Neuregulin 1/ErbB4 signaling contributes to the anti-epileptic effects of the ketogenic diet
by: Jin Wang, et al.
Published: (2021-02-01) -
A Role for Neuregulin-1 in Promoting Keloid
Fibroblast Migration via ErbB2-mediated Signaling
by: Natalie Jumper, et al.
Published: (2017-03-01) -
Neuregulin1-ErbB4 Signaling in Spinal Cord Participates in Electroacupuncture Analgesia in Inflammatory Pain
by: Chaofan Wan, et al.
Published: (2021-01-01) -
Increased Expression of Neuregulin 1 and erbB2 Tyrosine Kinase in the Bladder of Rats With Cyclophosphamide-Induced Interstitial Cystitis
by: Ki Hak Song, et al.
Published: (2015-09-01)